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summary of the two studies) does not mean that they were not
carefully applied. When such controls are introduced, the objection
concerning the posttest questionnaire loses weight. This conclusion
is clearly substantiated by the bulk of studies using different
masking procedures (dichotic listening, semantic priming, back-
ward masking, binocular rivalry, etc.), all reporting evidence of
nonconscious stimulus processing.
The second objection refers to the startle data themselves. It
seems surprising to Drs. Grillon and Cornwell that in study 1,
with only two trials, the second trial would not show the
expected habituation effect, raising concerns to researchers who
routinely use this technique. Therefore, the finding that the
startle response increased in the second trial, when participants
were shown the flower first and the spider second, is considered
evidence of a serious flaw in the method. The same argument is
applied to the first block of study 2. However, this argument, as
we explain below, rather than weakening, strengthens the
interpretation of the data as supporting the hypothesis of non-
conscious processing of the fearful stimulus. Our study 1 and the
first block of study 2 examine eyeblink startle in the context of
simultaneously examining cardiac defense. For this reason, as
reported in the paper, the intense acoustic stimulus had a
duration of 500 msec (instead of 50 msec) and an intertrial
interval of 120 sec. These are requirements well known to
researchers familiar with the cardiac defense methodology. Car-
diac defense is a robust phenomenon consistently reported in the
literature since Bond’s (1943) first description of the heart rate
response to ‘intense startling stimulation’ in cats and dogs (see
Turpin 1986; Vila et al. 1992). The response consists of a short
latency acceleration (peak around 3 sec), followed by a decelera-
tion, and then a long latency acceleration (peak between 30 and 40
sec), finishing with a second deceleration. This response pattern
habituates rapidly, almost disappearing after the first stimulus
presentation. For this reason, defense trials do not require a long
series of trials. But the same acoustic stimulus also produces a very
robust eyeblink startle response (when the stimulus has an instan-
taneous rise time) which, far from habituating, shows either no
habituation, in the first few trials, or a clear sensitization effect in the
second trial (see Ramírez et al. 2005; Mata et al. 2003). This
sensitization effect is not exclusive of defensive acoustic stimuli (500
msec). Researchers familiar with the typical startle methodology (50
msec) have also reported sensitization effects in the first few trials,
assuming that no practice trials are applied (see Bradley et al. 1996).
Drs. Grillon and Cornwell have also reported sensitization effects
under some emotional conditions. Therefore, our startle data should
not be puzzling, even for researchers who routinely use the typical
startle methodology. A potentiated startle when the spider is shown
in the second defense trial and no difference when the spider is
shown in the first defense trial is the correct confirmation of the
hypothesis. Finally, the results of study 1 concerning cardiac de-
fense (Ruiz-Padial et al. 2005) also strengthen this argument. In this
case, consistent with the fast habituation of the response, evidence
of nonconscious processing of the fearful stimulus comes from the
potentiated cardiac response when the spider was shown in the first
trial, no differences being detected when the spider was shown in
the second trial, just the opposite of the startle data, as expected.
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Low-Dose Tryptophan Depletion
To the Editor:
A cute tryptophan depletion (ATD) is a popular method toinvestigate the effects of lowered serotonin function inhumans. Acute tryptophan depletion induces a temporary
depressive ‘relapse’ in 50–60% of remitted depressed patients
treated with serotonergic antidepressants. In healthy individuals,
ATD has no or minor mood effects, but cognitive effects have
been found in both healthy and recovered depressed individuals
(Booij et al. 2003).
The magnitude of the reduction of plasma tryptophan con-
centrations following ATD depends on the amount and compo-
sition of the amino acid mixture (Young et al. 1989) and whether
a pre-test low tryptophan diet is included. It has been suggested
that a threshold exists that needs to be exceeded before any
behavioral effects occur, since studies in which the plasma
tryptophan reduction was lower than 70% generally do not find
any symptomatic effects (van der Does 2001b). However, de-
pression-congruent effects on sleep architecture have been ob-
served at moderate tryptophan reductions (Bhatti et al. 1998).
The placebo procedure developed by Krahn et al. (1996) may be
suitable as a low-dose ATD procedure (van der Does 2001a).
Since this procedure reduces plasma tryptophan concentrations
by 40 –50%, and has been found not to affect mood (Booij et al.
2005), it allows for the investigation of possible dose-response
effects.
Booij et al. (2005), using the Krahn et al. (1996) method as
low-dose ATD, found that ATD had a dose-dependent effect on
selective attention (Stroop color-word interference) in remitted
depressed patients, but no other cognitive effects of low-dose
ATD were observed. Merens et al. (unpublished data) observed
no effects of low-dose ATD on attention, memory, and accuracy
of emotion recognition in remitted depressed patients. Two
recent papers have reported much stronger effects of low-dose
ATD. Hayward et al. (2005) found that low-dose ATD had no
effects on mood ratings in unmedicated recovered depressed
subjects, but that it increased the emotion-potentiated startle
reflex, impaired recognition of happy faces and initial recall
memory and increased emotional Stroop interference. Some
cognitive effects were also observed in healthy controls. Munafò
et al. (2006) reported that low-dose ATD slightly increased
self-rated depressive symptoms in medicated recovered de-
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pressed patients and also increased Stroop interference for social
threat words.
The low-dose mixture used by Hayward et al. (2005) and
Munafò et al. (2006) consisted of eight amino-acids (31.2 g),
whereas the Krahn et al. (1996) procedure consists of 15
amino-acids (25.7 g). We calculated the plasma tryptophan
reductions obtained by Hayward et al. (2005), and found that
low-dose ATD decreased plasma tryptophan levels by 73.9% in
recovered depressed patients. The tryptophan/large neutral
amino acids (LNAA) ratio decreased by 86.9%. This suggests that
Hayward et al. (2005) studied high-dose ATD rather than low-
dose. The reductions cannot be calculated from the report by
Munafò et al. (2006), but this study used the same procedure and
partly the same sample. Viewing these studies as high-dose ATD
studies resolves the inconsistencies with the studies by Booij
et al. (2005) and Merens et al. (unpublished data). It also explains
the symptomatic effects in the Munafò et al. study. However,
high-dose ATD would be expected to have increased symptoms
in Hayward et al’s paper. This may be explained by the fact that
patients in this study had a relatively low number of previous
episodes, which predicts a weaker response to ATD (Booij et al.
2002).
There is no generally accepted definition of high-dose or
low-dose ATD. Hayward et al. (2005) presented their study as a
low-dose ATD study on the basis of the amount of amino acids
used. However, peripheral biochemical measures indicate that
this study may be considered a high-dose ATD study. In our
view, the term low-dose should reflect the decrease of plasma
tryptophan concentrations and not the amount and content of
the ATD mixture. Future research should carefully consider
which terminology is used to prevent misinterpretation and
biochemical data should be reported in detail.
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Reply to Low-Dose Tryptophan Depletion
To the Editor:
Weagree with Merens and van der Does that the effect ofacute tryptophan depletion (ATD) on brain serotoninfunction is likely to be dose-related and this in turn
must depend in part on the extent to which plasma tryptophan
(TRP) is lowered during the procedure. The aim of our study was
to find a dose of amino-acid mixture that did not cause depres-
sive relapse in recovered depressed patients so that we could
study the effect of lowered serotonin activity on emotional
processing in the absence of depressive symptomatology (Hay-
ward et al. 2005). In this respect, our design was successful, and
therefore the similarities between our study and that of Booij et
al. (2005) seem to us to be more important than the differences.
The report by Merens et al. (unpublished data) has yet to be fully
published, so we are not able to comment on how far the design
of the latter study informs the findings of Hayward et al. (2005).
Merens and van der Does suggest that the degree of TRP
depletion in plasma might be a better way of distinguishing high-
and low-dose ATD procedures. However, individual variation in
degree of plasma TRP depletion can be substantial, and differ-
ences in apparent TRP depletion will depend on the time at
which plasma TRP is sampled after depletion (5 hours in
Hayward et al. [2005] and 6 hours in Booij et al. [2005]).
Furthermore, the timing of the plasma TRP nadir can itself be
influenced by dose (Krahn et al. 1996). The difference in dose of
amino-acid mixture of the “low-dose” drink of Hayward et al.
(2005) and the standard ATD mixture is 50 –70 g, whereas the
difference in dose between that of Hayward et al. (2005) and the
“low-dose” drink of Booij et al. (2005) is  6 g. We doubt that the
small difference in dose between the latter two drinks will
produce sufficiently reliable differences in biochemical and
behavioral effects to merit one mixture being called “low-dose”
and the other not. We therefore respectfully suggest that the term
“low-dose” be retained to describe an ATD procedure that uses
a dose of amino acids substantially less than that of the conven-
tional mixture (80–100 g).
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